Piramal Pharma Limited Financial Ratios
PPLPHARMA · Healthcare · Current price ₹197.47
P/E ratio
-90.0x
P/B ratio
3.5x
ROE
-4.0%
ROCE
1.2%
Debt / Equity
0.67
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -90.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -4.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 1.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.67 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Piramal Pharma Limited's latest numbers.
Piramal Pharma Limited profitability
Piramal Pharma Limited generates a return on equity of -4.0% and a return on capital employed of 1.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.67 and a P/E of -90.0x, Piramal Pharma Limited is moderately leveraged. Our overall business-quality score for the company is 3.6 / 10.
Understand the ratios
More on Piramal Pharma Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.